#Microbiome Drugs Microbiome Drugs Market Microbiome Drugs Market 2020 Global Microbiome Drugs Market 2020 Microbiome Drugs Market Growth Mic | Explore Tumblr posts and blogs

marketing123456789 · 2 years ago

Text

Flavors for Pharmaceutical & Healthcare Applications Market Size, Industry Share, Development Trends, Growth and Global Scope, Opportunities and Competitive Landscape till 2033

The flavors for pharmaceutical and healthcare applications market was worth more than US$ 1.2 billion in 2023 and is estimated to expand at a CAGR of 5.5% from 2023 to 2033 due to the increasing incidence of medical problems worldwide.

Growing consumer awareness of the significance of physical well-being and fitness is cruising customer engagement in the consumption of nutritional supplements to boost immune function, resulting in greater product demand. Enhanced minerals and vitamin deficiency among the global population as a result of a dearth of consumption of nutrient-rich foods are likely to increase demand for flavors from dietary supplements.

The growing working-woman population and rising awareness about child nutritional requirements will drive flavor demand for infant nutrition compositions. Increasing clean label prerequisites are raising the significance of plant-based ingredients in pharmaceutical formulations, which is expected to expand market statistics during the forecast timeframe. The high demand for flavored infant formula and nutrients to augment food intake among kids is increasing the deployment of various flavors in infant nutrition, which is expected to enhance the business strategy in the APAC region over the next several decades.

Download Comprehensive Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15936

Key Takeaways from Market Study

By end use, dietary supplements are expected to witness significant growth, with revenue exceeding US$ 745 Million by 2033.

The omega fatty acid segment is anticipated to expand at a CAGR of more than 7.1% through 2033.

The European healthcare product flavors market is expected to exceed USD 335 million by 2033, with a CAGR of more than 5.2%.

Asia Pacific flavors market for the pharmaceutical and healthcare industry is anticipated to rise at a CAGR of more than 5.7% CAGR.

COVID-19 has contributed to the expansion of the flavors market for pharmaceutical and healthcare applications with a CAGR of 4%

Market Competition

Keva Flavours, Gold Coast Ingredients, International Flavours & Fragrances (IFF), Symrise AG, Prinova Nagasa Group, Mane SA, Firmenich, Taste Master Flavors, Wild Flavors & Specialty Ingredients, Quest Nutra Pharma, Concept Flavors & Fragrances, Carmi Flavors & Fragrances, and Sapphire Flavors & Fragrances, among others are some of the major players in the flavors market for pharmaceutical & healthcare applications.

Beta Heart, a new product from Herbalife Nutrition, was launched in January 2020. The product is particularly created to maintain blood cholesterol levels stable. Beta Heart, a vanilla-flavored product, is obtainable in a 15-gram sachet.

Firmenich, the world’s biggest private fragrance and flavor company, is delighted to announce dragon fruit as its 2023 Flavor of the Year, recognizing consumers’ desire for exciting new additives and bold, adventurous flavor creation.

Symrise AG took a further major leap forward to endorse manufacturers in October 2021 with the SymProBiomeTM platform. It encourages a deeper understanding of the fragile ecosystems that classify us as humans. Modern consumers desire products that are in tune with their bodies, harmonizing with their natural microbiomes and assisting them in looking and feeling better.

View Report@ https://www.futuremarketinsights.com/reports/flavors-for-pharmaceutical-and-healthcare-applications-market

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global flavors for pharmaceutical & healthcare applications market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023-2033.

The study reveals essential insights on the basis of end use (OTC drugs, dietary supplements, therapeutic nutrition and healthcare nutrition) across five major regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Key Segments Profiled in the Flavors Market for Pharmaceutical & Healthcare Applications Industry Survey

By End Use:

OTC Drugs

Dietary Supplements

Vitamins & Minerals

Proteins & Amino Acids

Dietary Fibers

Omega Fatty Acids

Botanicals

Therapeutic Nutrition

Healthcare Nutrition

Infant Nutrition

Sports Nutrition

Clinical Malnutrition

Others

By Region:

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

About Future Market Insights Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

0 notes

syndicatemarketresearch29 · 5 years ago

Text

Global Microbiome Drugs Market 2020 Global Analysis, Opportunities and Forecast to 2026

The Global Microbiome Drugs Market report explores the essential factors such as industry situations, market demands, market players adopted business strategies and their growth scenario. The Microbiome Drugs market report offers a forecast of revenue, CAGR, and cumulative revenue (covering USA, EU, China, Japan, India and etc). The Market study gives data with n-number of tables and figures examining the Microbiome Drugs, the research gives you a visual, one-stop breakdown of the leading products, submarkets and market leader’s market revenue forecasts as well as analysis to 2026. The market is growing with technological innovation, competition and M&A activities in the industry are offering specific application products for varied end-users. Key manufacturers of Global Microbiome Drugs Market, listed here are Pfizer, Second Genome, Seres Therapeutics, MaaT Pharma, Enterome Bioscience, MicroBiome Therapeutics, Ritter Pharmaceuticals, Rebiotix, OpenBiome.The report provides an overview of the players operating in the market, the strategies deployed by them to gain competitive advantage, the annual revenue generated by them in the historical years, and their relevant business segment revenue.

Request for Sample Report @ https://www.syndicatemarketresearch.com/market-analysis/microbiome-drugs-market.html#sample

The Microbiome Drugs market delivers a wide array of primary and secondary data with respect to regional and global market. In-depth analysis of numerous components has been studied in the report including supply and demand Figures, cost, price, revenue, gross margins, current geographical zones, technology, demand-supply and consumption. The market study focuses on industry dynamics including driving factors to provide the key elements fueling the current market growth. The report also identifies restraints and opportunities to identify high growth segments involved in Microbiome Drugs market. In addition to this, the study provides Porters five forces analysis, PESTEL analysis and industry chain analysis of the Microbiome Drugs market to gain the impact of various factors such as bargaining power of suppliers, competitive rivalry, threat of new entrants, threat of substitutes, and bargaining power of buyers on the growth of Microbiome Drugs market.

This report studies Microbiome Drugs in global market with production, revenue, consumption, sales, import and export, market share and growth rate of forecast period 2019-2025. The Microbiome Drugs market report gathered information holds important information which has been shared in a precise and structured manner using a number of monographs, tables, pie charts and bar-graphs. In the end, the report makes some important proposals for a new project of Microbiome Drugs market before evaluating its feasibility. The solid research on the Microbiome Drugs Market is prepared with the aim to meet the requirements of the customer in terms of the availability of data, analytics, statistics, and an accurate forecast market.The market report also presents the landscape and a corresponding detailed analysis of the major players operating in the market. The market report analyses the market potential for each geographical region based on the growth rate, consumer buying patterns, and market demand and supply scenarios.

Market Analysis by Regions: Each geographical region is analyzed as Sales, Market Share (%) by Types & Applications, Production, Consumption, Imports & Exports Analysis, and Consumption Forecast. USA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.

Segment by Type, Global Microbiome Drugs Market can be split into: Probiotics, Prebiotics, Small Molecules, Biological Drugs, Other

Segment by Applications, Global Microbiome Drugs Market can be split into: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other

Reasons to Purchase this Microbiome Drugs market Report:

1) Analyzing the outlook of the market with the recent trends and SWOT analysis 2) Microbiome Drugs Market dynamics scenario, along with growth opportunities of the market in the years to come 3) Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects 4) Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the Microbiome Drugs market. 5) Market value (USD Million) and volume (Units Million) data for each segment and sub-segment 6) Competitive landscape involving Microbiome Drugs market share of major players, along with the new projects and strategies adopted by players in the past five years 7) Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major Microbiome Drugs market players

The Microbiome Drugs market report provides answers to the following key questions:

- What will be the Microbiome Drugs market size and the growth rate in 2025? - What are the main key factors driving the global Microbiome Drugs market? - What are the key market trends impacting the growth of the global Microbiome Drugs market? - Which Trending factors influencing the market shares of the top regions across the globe? - Who are the key market players and what are their strategies in the global Microbiome Drugs market? - What are the market opportunities and threats faced by the vendors in the global Microbiome Drugs market? - What industrial trends, drivers and challenges are manipulating its growth? - What are the key outcomes of the five forces analysis of the global Microbiome Drugs market?

Inquiry for Buying Repor @ https://www.syndicatemarketresearch.com/inquiry/microbiome-drugs-market

In conclusion, Microbiome Drugs market report presents the descriptive analysis of the parent market supported elite players, present, past and artistic movement information which is able to function a profitable guide for all the Microbiome Drugs Industry business competitors.Our expert research analyst’s team has been trained to provide in-depth market research report from every individual sector which will be helpful to understand the industry data in the most precise way.

#Microbiome Drugs Microbiome Drugs Market Microbiome Drugs Market 2020 Global Microbiome Drugs Market 2020 Microbiome Drugs Market Growth Mic

0 notes

pranalipawarshinde · 2 years ago

Text

Human Microbiome Market to expand at a CAGR of 7.1% from 2021 to 2028

Human Microbiome Market: Introduction

According to the report, the global human microbiome market was valued at US$ 1.3 Bn in 2020 and is projected to expand at a CAGR of 7.1% from 2021 to 2028. Microbiome is the genetic component of the entire range of microorganisms, including bacteria, fungi, protozoa, and viruses, which live inside and on the human body. The beneficial bacteria present in the microbiome assist the digestion of food, regulation of the immune system, and protection against other disease-causing bacteria.

This ability is being harnessed by start-ups and companies in the microbiome-based therapeutics market to create drugs aimed at treating conditions, which have been shown to have a link with imbalance in the microbiome. The human microbiome market has been analyzed by studying it as two individual markets, the microbiome-based diagnostics market and the microbiome-based therapeutics market.

Request a PDF Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3999

Mergers & Acquisition and Innovation among Key Players to Drive Global Market

In August 2020, Seres Therapeutics announced the success of its flagship product SER-109 in the phase 3 trail. SER-109 treatment is likely to reduce the risk of gastrointestinal infection caused by Clostridium difficile. In May 2020, Rebiotix and Ferring Pharmaceuticals announced positive result from the preliminary phase 3 data from fecal microbial transplantation product RBX2660.

In June 2020, Debiopharm and Takeda Pharmaceutical Company entered into partnership to develop the microbiome therapeutics for the treatment of the IBD and other gastrointestinal diseases. In April 2020, Second Genome and Gilead Sciences, Inc. entered into partnership to identify the biomarkers for Gilead clinical candidates & drug targets for IBD. Moreover, in February 2020, Enterome partnered with the BIOASTAR Institute to explore the microbiome derived cancer immunotherapies. In November 2019, Finch extended its partnerships with Takeda for developing microbiome-based therapeutics by utilizing Finch human first discovery platform

Increase in Research & Development Activities in Metagenomics and Next-generation Sequencing Render Microbiome-based Testing Easier and Cheaper

Advances in metagenomics and next-generation sequencing have made microbiome-based testing easier and cheaper, paving the way to carry out rapid analysis of the genomic content of microorganisms from human sample. This has strengthened the development process for microbiome-based diagnostics.

Gastrointestinal and metabolic disorders are likely to capture the leading share of the diagnostics market in 2020, owing to rise in focus of companies toward developing an easy analysis platform for gut health-based disorders, such as irritable bowel syndrome and Crohn’s disease.

Request Report Methodology@ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=3999

For instance, Metabiomics is developing molecular diagnostics for detecting markers of colorectal cancer. Existing tests for colorectal cancer rely on invasive colonoscopies. Hence, the non-invasive test developed by Metabiomics (which uses a stool sample to evaluate patient’s gut microbiome) will be a unique opportunity for the company to excel in a market having huge unmet needs.

Metagenomic Sequencing Segment to Grow at High Rate

In terms of technology, the global human microbiome market has been bifurcated into metagenomic sequencing and 16s rRNA sequencing. The metagenomic sequencing segment is likely to expand at a higher CAGR from 2021 to 2028. Growth of the segment can be attributed to the preference of start-ups in providing comprehensive data profiles of the inherent microbiome of the individual being tested. Rise in investments by companies and partnerships, which provide unique opportunity for companies to offer technology-driven products in the market is anticipated to propel the segment during the forecast period.

GI & Metabolic Disorders Segment to Dominate Human Microbiome Market

Based on indication, the global human microbiome market has been classified into gastrointestinal & metabolic disorders, women’s health, cancer, and others. The gastrointestinal & metabolic disorders segment dominated the global market in 2020 and the trend is projected to continue during the forecast period. The segment is driven by focus on these diseases by leading companies in the market. uBiome, a market leader in the microbiome diagnostics market, recently launched SmartGut for microorganisms associated with several common gut symptoms such as Crohn’s disease and ulcerative colitis.

Request For Custom Research@ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3999

The growth of the segment can be attributed to high number of microbiome diagnostic companies and ease of non-invasive testing provided by this method.

North America to Dominate Global Market

In terms of region, the global human microbiome market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global human microbiome market in 2020, followed by Europe. North America is likely to dominate the human microbiome market, attributed to rise in investments in research & development, ongoing clinical trials for conducting microbiome projects, stringent governmental regulations, and technological advancements. Large number of programs in clinical stage in North America and increase in awareness about the concept of microbiome-based therapies are few driving factors for the regional growth of the market.

Europe is likely to account for the second-largest share of the global human microbiome market during the forecast period, owing to prominent contribution of companies in the microbiome research and diagnostics. Most of the therapies in the pipeline is anticipated to be first released in the region. This is likely to propel the human microbiome market in Europe during the forecast period.

Request For Custom Research@ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3999

Competition Landscape

The global human microbiome market is consolidated in terms of number of players. Key players in the global market include AOBiome, Enterome Biosciences SA, Metabiomics Corp. (BioSpherex LLC), Microbiome Therapeutics LLC, Osel, Inc., Second Genome, Seres Therapeutics, Synthetic Biologics, Inc., Vedanta Biosciences, 4D Pharma, and Ferring Pharmaceuticals

More Trending Reports by Transparency Market Research:

Cancer Biomarkers Market@ https://www.transparencymarketresearch.com/cancer-biomarkers-market.html

Analytical Standards Market@ https://www.transparencymarketresearch.com/analytical-standards-market.html

Mice Model Technologies Market@ https://www.transparencymarketresearch.com/mice-model-technologies-market.html

Soft Tissue Allografts Market@ https://www.transparencymarketresearch.com/soft-tissue-allografts-market.html

Animal Genetics Market@ https://www.transparencymarketresearch.com/animal-genetics-market.html

Transplant Drug Monitoring Assay Market@ https://www.transparencymarketresearch.com/transplant-drug-monitoring-assay-market.html

PRP and PRF in Cosmetics Market@ https://www.transparencymarketresearch.com/prp-and-prf-in-cosmetics-market.html

Fetal Bovine Serum Market@ https://www.transparencymarketresearch.com/fetal-bovine-serum-market.html

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email: [email protected]

0 notes

healthcare-market · 3 years ago

Text

Human Microbiome Market Report Analysis With Industry Share Insights Shared in Detailed Report

Human Microbiome Market: Introduction

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3999

Mergers & Acquisition and Innovation among Key Players to Drive Global Market

Request for Analysis of COVID19 Impact on Human Microbiome Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=3999

Increase in Research & Development Activities in Metagenomics and Next-generation Sequencing Render Microbiome-based Testing Easier and Cheaper

Request a Sample of Human Microbiome Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3999

Metagenomic Sequencing Segment to Grow at High Rate

GI & Metabolic Disorders Segment to Dominate Human Microbiome Market

The growth of the segment can be attributed to high number of microbiome diagnostic companies and ease of non-invasive testing provided by this method.

Enquiry before Buying Human Microbiome Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=3999

North America to Dominate Global Market

Competition Landscape

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/healthcare-biometrics-market-to-rise-at-cagr-of-15-5-during-forecast-period-notes-tmr-study-301509175.html

https://www.globenewswire.com/news-release/2022/03/03/2395966/0/en/Teleradiology-Services-Market-predicted-to-Clock-whopping-11-CAGR-from-2021-to-2031-Says-TMR.html

https://www.globenewswire.com/news-release/2022/03/10/2401154/0/en/Platelet-rich-Plasma-Market-to-Grow-at-CAGR-of-11-2-During-Forecast-Period-Notes-TMR-Study.html

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected]

Website: https://www.transparencymarketresearch.com/

0 notes

industry365 · 3 years ago

Text

Human Microbiome Therapeutics Market Is Expected To Reach New Growth Revenues During 2021-2028

The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research. The report “Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others); By Indication (Acne Vulgaris, Atopic Dermatitis, Clostridium difficile Infection, Colorectal Cancer, Diabetes, Inflammatory Bowel Disease (IBD), Lactose Intolerance, Lung Cancer, Non-alcoholic steatohepatitis (NASH), Obesity, and Coeliac Disease); By Approach (Small Molecule Therapies, Single Strain Whole Bacteria, Microbial Consortia, Genetically Modified Single Strain Bacteria, Phage Cocktail, and Microbial Ecosystems), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut. The human body comprises more than 100 trillion microbes and around 2 million microbe genomes. These microbiota plays a significant role in the body’s physiological functions and includes viruses, bacteria, and fungi. Primarily it has Bacteroidetes (gram negative) and Firmicutes, commonly Clostridium and Lactobacillus sp. (gram positive). The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.

Download sample: https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-sample

The global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects. In November 2019, the Million Microbiome of Humans Project (MMHP) was launched in collaboration with France, Denmark, China, Latvia, Sweden and other countries to co-operate in meta-genomic research. The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.

Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I. du Pont de Nemours and Company, Finch Therapeutics, GNUbiotics Sciences, ClearB Therapeutics, GoodBelly, GoodGut, Synlogic, Second Genome, 16S Technologies, 5QBD-Biotech, Vedanta Biosciences, Holobiome, Commense, Ferring Pharmaceuticals, Evelo Biosciences, CoreBiome, Igen Biolab Group, ViThera Pharmaceuticals, DermBiont, Hyggut, Embion Technologies, Lactobio, BiomX, Exeliom Biosciences, and LNC Therapeutics are some of the key players operating in the concerned market.

VID-19 is open, and dosing to start very soon. The company is world leader in the production of live bio-therapeutics (live microbiome used to cure disease). Its products are the orally delivered single strain bacteria, which are naturally present in the human gut.

Get Discount offer: https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-discount-pricing

Polaris Market research has segmented the Human Microbiome Therapeutics market report on the basis of product, therapeutic area, indication, approach, and region

Human Microbiome Therapeutics Product Outlook (Revenue – USD Million, 2016 – 2027)

Probiotics

Prebiotics

Medical Foods

Prescription Drugs

Human Microbiome Therapeutic Area Outlook (Revenue – USD Million, 2016 – 2027)

Autoimmune Disorders

Dental Disorders

Digestive and Gastrointestinal Disorders

Dermatological Disorders

Infectious Disease

Metabolic Disorders

Oncology

Others

Human Microbiome Therapeutics Indication Outlook (Revenue – USD Million, 2016 – 2027)

Acne Vulgaris

Atopic Dermatitis

Clostridium Difficile Infection

Colorectal Cancer

Diabetes

Inflammatory Bowel Disease (IBD)

Lactose Intolerance

Lung Cancer

Non-alcoholic steatohepatitis (NASH)

Obesity

Coeliac Disease

Human Microbiome Therapeutics Approach Outlook (Revenue – USD Million, 2016 – 2027)

Small Molecule Therapies

Single Strain Whole Bacteria

Microbial Consortia

Genetically Modified Single Strain Bacteria

Phage Cocktail

Microbial Ecosystems

Human Microbiome Therapeutics Regional Outlook (Revenue – USD Million, 2016 – 2027)

North America

Europe

Asia Pacific

Central & South America

Middle East & Africa

U.S.

Canada

France

Germany

Italy

Netherlands

Spain

Austria

China

India

Japan

Malaysia

Australia

South Korea

Mexico

Brazil

Argentina

UAE

Saudi Arabia

Israel

South Africa

Buy Now: https://www.polarismarketresearch.com/checkouts/6541

0 notes

businessconsultingarticle · 3 years ago

Text

Probiotic Cosmetic Products Market Global Industry Perspective, Comprehensive Analysis, And Forecast, 2028

The global probiotic cosmetic products market size was valued at USD 268.91 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.5% during the forecast period.

Probiotics are live microorganisms that, when administered in adequate amounts, are capable of giving health benefits to the skin by helping to balance the skin microbiota, strengthen the skin barrier to promote tissue repair, reduce sensitivity, control acne and dermatitis, fight the action of free radicals, and prevent premature aging.

The microbiome movement is gaining traction around the world as more consumers become aware how to care for the skin's microbiota. Using probiotic cosmetics has emerged as one of the best ways to care for the skin microbiome. Experts are of the opinion that taking care of the skin's microbiota is especially important at current times due to modern lifestyles with hot baths and poorly balanced diets. The delicate ecosystem of the skin undergoes constant aggressions that impair its balance, that leads to drier, inflamed skin. Such factors are working in favour for the growth of probiotic cosmetics market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3837

Probiotic cosmetic products can help reduce acne, eczema, rosacea, and chronic inflammation. Increasing awareness about probiotic as a beneficial element and concerns related to skin problems, such as damaged skin, acne, breakouts, eczema, and psoriasis, are key factor driving the market growth.

One of the restrains for the market is expected to be the high price of probiotic cosmetic products. The Coronavirus pandemic also played a considerable role in the probiotic cosmetic products industry. Though there was a dramatic decline in revenue due to shop closures and stay-home policies, skincare routine became massively popular as people had more time to indulge in such routines. Though there was a decline in makeup usage, consumers made newer discoveries regarding skincare and experimented with such products as probiotic cosmetics. Though a decline in economy due to the pandemic does not bode well for the beauty industry, its effects are expected to be temporary.

Some of the key players operating in the global probiotic cosmetic products market are: Esse Skincare, Estee Lauder Companies, Inc., Aurelia Skincare Ltd., L’oreal S.A., Tula Life, Inc., Eminence Organic Skincare, Unilever, LaFlore Probiotic Skincare, Glowbiotics, Inc., The Clorox Co. among others.

Segments Covered in the Report

Product outlook (Revenue, USD Million, 2018 - 2028)

Skin care

Hair care

Distribution Channel Outlook (Revenue, USD Million, 2018 - 2028)

Hypermarket & Supermarket

Pharmacy & Drug Store

E-commerce

Others

Regional Outlook (Revenue, USD Million, 2018 - 2028)

North America

Europe

Asia Pacific

Central & South America

Middle East & Africa (MEA)

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3837

Key Highlights from the Report: In April 2020, Estee Lauder launched Futurist Hydra Rescue Moisturizing Makeup that is infused with Ion Charged Water, as well as probiotics and chia-seed extract which help the skin to stay hydrated.

The skin care segment led the market and accounted for more than 90% share of the global revenue in 2019. Probiotics used as a relief ingredient against skin problems, such as acne, blemishes, wrinkles, and others, is the key factor driving the segment growth.

E-commerce distribution channel segment is however expected to gain considerable traction as e-commerce channels are known for providing considerable discounts on cosmetic products. Additionally, many consumers make the choice of buying products from online stores once they come to trust the product.

The region of North America dominated the market in 2019 and accounted for over 34% of the global share of sales. The demand for probiotic cosmetics in the area is driven by increasing concerns about acne and various skin diseases. To gain a foothold in the industry, prospective manufacturers have concentrated on product innovation

During the forecast period, Asia Pacific is projected to be the fastest-growing regional market. The regional market is expected to be guided by factors such as growing consciousness about following safe skin habits, product developments, and the need for a long-term solution to skin problems.

To know more about the report @ https://www.reportsanddata.com/report-detail/probiotic-cosmetic-products-market

Key Features of the Probiotic Cosmetic Products Analysis Market Report:

· The report offers a comprehensive analysis of the changing competitive dynamics.

· Provides a futuristic outlook on the key market drivers and restraining factors.

· A comprehensive 8-year forecast of the market and its expected growth rate and pattern.

· In-depth analysis of the key product segments and application spectrum

· Provides strategic recommendations to the established companies and new entrants to provide a competitive advantage over the other companies.

· Comprehensive analysis of the key regions of the industry and provides a SWOT analysis and Porter’s Five Forces analysis to impart a deeper understanding of the market.

· Helps in formulating strategic business decisions and investments plans.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3837

Thank you for reading our report. For further query on the report and customization, please connect with us. Our team will ensure you get the report best suited for your needs.

Explore More Related Reports:

Jewelry Market @ https://www.reportsanddata.com/blog/the-jewelry-industry-in-2020-and-beyond-top-10-companies-in-the-market

Probiotic Cosmetic Products Market @ https://www.reportsanddata.com/report-detail/probiotic-cosmetic-products-market

Personal Care Appliances Market @ https://www.reportsanddata.com/report-detail/personal-care-appliances-market

Remote Deposit Capture Market @ https://www.reportsanddata.com/report-detail/remote-deposit-capture-market

Electronic Shelf Label (ESL) Market @ https://www.reportsanddata.com/report-detail/electronic-shelf-label-esl-market

Floodlight Cameras Market @ https://www.reportsanddata.com/report-detail/floodlight-cameras-market

About Reports and Data Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

#Probiotic Cosmetic Products Market #Probiotic Cosmetic Products Market trends #Probiotic Cosmetic Products Market size

0 notes

reportmines05 · 3 years ago

Text

Microbiology Analyzers Market Analysis 2020-2025

Microbiology analyzers are utilized in numerous research center examinations that look to uncover the idea of microbiology and the control and development of microorganisms. This instrument is valuable for different applications in microbiology and is helpful in measurable microbiology research facilities. microbiology analyzers are utilized in legal sciences to decide the wellspring of a wrongdoing by inspecting body liquids, discharges, messes, filaments or semen for proof of a wrongdoing. It is additionally helpful for fostering a hereditary profile from tests that are submitted as proof in judicial actions.

Our other reports -

Solder Resist Ink Market Research Report Analysis By Competition, Sales, Revenue, Market Size, Share And Forecasted Data From 2021 To 2027 By ReportMines

Etching Resist Ink Market Research Report Analysis By Competition, Sales, Revenue, Market Size, Share And Forecasted Data From 2021 To 2027 By ReportMines

Industrial Oven Market Research Report Analysis By Competition, Sales, Revenue, Market Size, Share And Forecasted Data From 2021 To 2027 By ReportMines

Water Cooled Chillers Market Research Report Analysis By Competition, Sales, Revenue, Market Size, Share And Forecasted Data From 2021 To 2027 By ReportMines

Bowling Centers Market Research Report Analysis By Competition, Sales, Revenue, Market Size, Share And Forecasted Data From 2021 To 2027 By ReportMines

Film Dubbing Market Research Report Analysis By Competition, Sales, Revenue, Market Size, Share And Forecasted Data From 2021 To 2027 By ReportMines

Dyes And Pigments Market Research Report Analysis By Competition, Sales, Revenue, Market Size, Share And Forecasted Data From 2021 To 2027 By ReportMines

Welded Wire Mesh Panel Market Research Report Analysis By Competition, Sales, Revenue, Market Size, Share And Forecasted Data From 2021 To 2027 By ReportMines

Chemical Tankers Market Research Report Analysis By Competition, Sales, Revenue, Market Size, Share And Forecasted Data From 2021 To 2027 By ReportMines

Automotive Central Gateway Module Market Research Report Analysis By Competition, Sales, Revenue, Market Size, Share And Forecasted Data From 2021 To 2027 By ReportMines

Microbiology analyzers are accessible in different models and plans and come in various sorts and limits. They can be utilized to examine an assortment of fluids, for example, sera, blood, pee, stool, cerebrospinal liquid, strong squanders and cell and noncellular trash from human or creature sources. These instruments are worked to be touchy to a natural defilement and are usually utilized in clinical microbiology research centers. The clinical microbiology market is expected to develop at a noteworthy rate throughout the following decade. The clinical microbiology market is driven by an expanding occurrence of pathogenic contaminations and antimicrobial opposition among novel strains of microscopic organisms and parasites. These instruments empower microbiology specialists to decide the wellspring of defilement, to follow its source through investigation and to build up the species in question.

Get Microbiology Analyzers market Research Report :

https://www.reportmines.com/global-microbiology-testing-clinical-microbiology-market-r21176

microbiology analyzers are intended to yield dependable, information driven outcomes that address the issues of end clients and partners. The report extent of administration of these instruments incorporates investigation of microbiology tests gathered from different areas. Tests might be gathered from clinical, regulatory, ecological, drug, word related or research settings. In light of the data yielded from the examples, a last report is created which is shipped off the end clients or partners.

microbiology analyzers research likewise work with the ideal evaluation and recognizable proof of wellsprings of microbiology defilement, which could fundamentally affect end clients, staffs and the more extensive natural climate. A wide scope of scientific strategies are used in the clinical microbiology analyzers, contingent upon the idea of the example and the ideal report scope. Tests might be examined for species bounty, pH, tainting design, quantitative information, differential culture as well as stool culture, and additionally for differential development and local area structure. The scientific convention can be recorded or customized into a PC program, contingent upon the requirements of the end clients or partners.

microbiology analyzers are by and large intended to deal with a solitary or different clinical research facility or end client destinations. A few instances of microbiology analyzers are work area, mechanized, continuous, instrumented and consumables market. Every analyzer enjoys its own benefits and hindrances and the decision of the right sort and sort of instrument relies upon the sort of use. The quantity of species to be tried is restricted by the accessibility of the example. The utilization of anti-microbials and other microbiology analyzers is expanding worldwide determined to keep up with and upgrading human wellbeing and as a pointer of natural medical issues.

As a feature of test assortment methods, microbiology analyzers are utilized to gather microorganisms from different example sources. Analyzers are sorted into two sections: essential and auxiliary metabolites. The fundamental uses of these are for the clinical microbiology analyzers, however they are additionally utilized in the field of supplement investigation, blood, serum and other blood-borne microorganisms, in the area of microbiology, biology and immunology and in the nourishment and microbiology markets.

Synopsis

The report gauge worldwide Microbiology Testing Clinical Microbiology market to develop to arrive at xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to Covid circumstance.

The report offers definite inclusion of Microbiology Testing Clinical Microbiology industry and fundamental market patterns with effect of Covid. The statistical surveying incorporates chronicled and figure market information, request, application subtleties, value patterns, and friends portions of the main Microbiology Testing Clinical Microbiology by geology. The report parts the market size, by volume and worth, based on application type and topography.

To begin with, this report covers the current status and the future possibilities of the worldwide Microbiology Testing Clinical Microbiology market for 2015-2024.

Furthermore, in this report, we investigate worldwide market from 5 topographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East and Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Simultaneously, we arrange Microbiology Testing Clinical Microbiology as indicated by the sort, application by topography. All the more significantly, the report incorporates significant nations market dependent on the kind and application.

At long last, the report gives definite profile and information data investigation of driving Microbiology Testing Clinical Microbiology organization.

Key Content of Chapters as follows (Including and can be redone) :

Section 1:

Market Overview, Development, and Segment by Type, Application and Region

Section 2:

Organization data, Sales, Cost, Margin and so forth

Section 3:

Worldwide Market by organization, Type, Application and Geography

Section 4:

Asia-Pacific Market by Type, Application and Geography

Section 5:

Europe Market by Type, Application and Geography

Section 6:

North America Market by Type, Application and Geography

Section 7:

South America Market by Type, Application and Geography

Section 8:

Center East and Africa Market by Type, Application and Geography

Section 9:

Market Features

Section 10:

Venture Opportunity

Section 11:

Conclusion

Market Segment as follows:

By Region

Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]

Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

North America[United States, Canada, Mexico]

Middle East & Africa[GCC, North Africa, South Africa]

South America[Brazil, Argentina, Columbia, Chile, Peru]

Key Companies

Biomerieux S.A.

Danaher

Becton, Dickinson and Company

Cepheid

Abbott

Alere

Bio-Rad Laboratories

Hologic

Bruker

F.Hoffmann-La Roche Ltd

Market by Type

Laboratory Instruments,include Incubators,Gram Stainers,Bacterial Colony Counters,Autoclave Sterilizers,Microbial Air Samplers,Anaerobic Culture Systems,Petri Dish Fillers,Blood Culture Systems,Microbial Culture Systems

Microbiology Analyzers,include Molecular Diagnostic Instruments,Microscopes,Mass Spectrometers

Reagents,include Pathogen-Specific Kits,General Reagents

Market by Application

Pharmaceutical

Clinical

Manufacturing

Energy

Respiratory Diseases

Food Testing Applications

Environmental Applications

Instruments

Analyzers

Consumables

Frequently Asked QuestionsWhat is the USP of the report?

Global Microbiology Testing Clinical Microbiology Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.

What are the key content of the report?What are the value propositions and opportunities offered in this market research report?Related Reports

Global Microbiology Testing Market

Global Microbiome Sequencing Services Market

Global MicroBulk Delivery Systems Market

Global Micro-channel Plate Market

#Microbiology Analyzers

0 notes

linhgd9 · 3 years ago

Text

Central Nervous System Treatment Market to Rise at an Accelerated Pace Backed by Rising Pharmaceutical Sector in North America

The global “central nervous system treatment market” is expected to gain momentum in the forthcoming years. This is attributable to the increasing prevalence of neurological disorders and the availability of advanced healthcare facilities in developed and emerging economies that propel the adoption of novel central nervous system treatment solutions globally. Fortune Business Insights published this information in its upcoming report, titled, “Central Nervous System Treatment Market Size, Share & Industry Analysis, By Drug Class (Analgesics, Anesthetics, Anticonvulsants, Antiemetics, Antiparkinson Agents), By Disease Indication (Neurovascular Disease, Degenerative Disorders, Mental Health & Trauma, Others), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) and regional forecast 2020-2027.”

The widespread effect of the global pandemic, COVID-19, has been felt across several economies that are facing unprecedented loss. Owing to the lockdown announced by the government agencies, several industries have been on a standstill with limited operational activities. However, a collective effort from the government as well as the industries is likely to bring the economy back on track and aid in the resumption of industrial activities.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/sample/central-nervous-system-treatment-market-103973

The central nervous system (CNS) is a vital system of the human body that controls major functions of the body and mind. It primarily has three significant functions that include information processing, sensory input, and motor output. The failure of CNS leads to several adverse health effects such as memory loss, weakness, numbness, lack of coordination, and loss of sight, among others. However, to counter this condition, several central nervous system treatment options are in the offing across the healthcare facilities worldwide.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit:https://www.fortunebusinessinsights.com/central-nervous-system-treatment-market-103973

DRIVING FACTORS

Increasing Incidence of Neurological Disorders to Feed Market Growth

According to the World Health Organization (WHO), around 1.2 million adult-onset brain disorders diagnosed are due to Alzheimer disease. Additionally, over 60,000 Americans are diagnosed with Parkinson’s disease in the United States. The increasing prevalence of neurological disorders is expected to boost the adoption of advanced central nervous system treatment solutions during the forecast period. Moreover, availability of advanced healthcare facilities is expected to contribute to the global central nervous system treatmentmarket in the forthcoming years.

REGIONAL INSIGHTS

Growing Pharmaceutical Sector in North America to Accelerate Growth

Among all the regions, North America is expected to remain dominant and hold the highest position in the global central nervous system treatment market during the forecast period. This dominance is attributable to the growing pharmaceutical sector that supports the adoption of advanced central nervous system treatment solutions in the region.

On the other hand, Europe is expected to hold the second position in the market owing to the increasing demand for therapeutic drugs in the region between 2020 and 2027.

COMPETITIVE LANDSCAPE

Increasing Investment in R&D Activities by Prominent Companies to Boost Product Adoption

The global central nervous system treatment market is consolidated by the presence of major companies that are investing in R&D activities to develop novel central nervous system treatment solutions. Additionally, other key players are adopting strategies such as collaborations and partnerships that are likely to bode well for the market growth during the forecast period.

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/sample/central-nervous-system-treatment-market-103973

Industry Development:

December 2020 – Innovent Biologics, Inc., a leading biopharmaceutical company, announced the approval of its recombinant humanized anti-VEGF monoclonal antibody drug, BYVASDA by the National Medical Products Administration (NMPA) of China. The company reports that the central nervous system treatment solution is an effective therapeutic drug that can be used for treating glioblastoma patients.

List of the Companies Profiled in the Global Market for Central Nervous System Treatment:

Eli Lilly and Company

Pfizer Inc.

Otsuka America Pharmaceutical, Inc.

Biogen

AstraZeneca

Novartis AG

Takeda

Merck & Co., Inc.

Teva Pharmaceutical Industries Ltd.

Johnson & Johnson Services, Inc.

Others

About Us:

Fortune Business Insights

offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights

we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Fortune Business Insights

Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Fortune Business Insights

LinkedIn | Twitter | Blogs

Related Reports :

Feeding Tubes Market

Feeding Tubes Market Size

Feeding Tubes Market Share

Feeding Tubes Market Trends

Feeding Tubes Market Growth

Feeding Tubes Market Analysis

Feeding Tubes Market Business Opportunities

Feeding Tubes Market Key Players

Feeding Tubes Market Demand

Feeding Tubes Market Competitive Landscape

Microbiome Therapeutics Market Segments

Microbiome Therapeutics Market Overview

Microbiome Therapeutics Industry

Microbiome Therapeutics Market Stastistic

Microbiome Therapeutics Market Devlopment Strategy

Microbiome Therapeutics Market Future Growth

Microbiome Therapeutics Market Research Methodology

Microbiome Therapeutics Market Drivers

Microbiome Therapeutics Market Manufacturers

Microbiome Therapeutics Market Revenue

from NeighborWebSJ https://ift.tt/3zLz5yc via IFTTT

from WordPress https://ift.tt/3xLcGPH via IFTTT

#WordPress

0 notes

newsbulletin · 4 years ago

Text

Human Microbiome Therapeutics Market Detailed Analysis, Challenges And Forecast 2027

New York, NY 14 May 2021: The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research. The report “Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others); By Indication (Acne Vulgaris, Atopic Dermatitis, Clostridium difficile Infection, Colorectal Cancer, Diabetes, Inflammatory Bowel Disease (IBD), Lactose Intolerance, Lung Cancer, Non-alcoholic steatohepatitis (NASH), Obesity, and Coeliac Disease); By Approach (Small Molecule Therapies, Single Strain Whole Bacteria, Microbial Consortia, Genetically Modified Single Strain Bacteria, Phage Cocktail, and Microbial Ecosystems), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-sample

Recently, in July 2020, 4D pharma plc., the UK based pharma company engaged in the development of live bio-therapeutics announced that patient enrollment for its phase II trial of its candidate oral immune-modulator MRx-4DP0004 for patients hospitalized with COVID-19 is open, and dosing to start very soon. The company is world leader in the production of live bio-therapeutics (live microbiome used to cure disease). Its products are the orally delivered single strain bacteria, which are naturally present in the human gut.

To get Incredible Discounts on this Premium Report, Click At: https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-discount-pricing

Polaris Market research has segmented the Human Microbiome Therapeutics market report on the basis of product, therapeutic area, indication, approach, and region

Human Microbiome Therapeutics Product Outlook (Revenue – USD Million, 2016 – 2027)

Probiotics

Prebiotics

Medical Foods

Prescription Drugs

Human Microbiome Therapeutic Area Outlook (Revenue – USD Million, 2016 – 2027)

Autoimmune Disorders

Dental Disorders

Digestive and Gastrointestinal Disorders

Dermatological Disorders

Infectious Disease

Metabolic Disorders

Oncology

Others

Human Microbiome Therapeutics Indication Outlook (Revenue – USD Million, 2016 – 2027)

Acne Vulgaris

Atopic Dermatitis

Clostridium Difficile Infection

Colorectal Cancer

Diabetes

Inflammatory Bowel Disease (IBD)

Lactose Intolerance

Lung Cancer

Non-alcoholic steatohepatitis (NASH)

Obesity

Coeliac Disease

Human Microbiome Therapeutics Approach Outlook (Revenue – USD Million, 2016 – 2027)

Small Molecule Therapies

Single Strain Whole Bacteria

Microbial Consortia

Genetically Modified Single Strain Bacteria

Phage Cocktail

Microbial Ecosystems

Have Any Query or Specific Requirement? Request for customization: https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-customization

About Polaris Market Research

Polaris Market Research

Phone: 1–646–568–9980

Email: [email protected]

Web: http://www.polarismarketresearch.com

#Human Microbiome Therapeutics market Human Microbiome Therapeutics Insight Human Microbiome Therapeutics Growth

0 notes

rdclsuperfoods · 4 years ago

Link

Probiotic supplements aren’t just trendy, they’re ubiquitous. You can find bottles of probiotic pills, powders, and liquids for sale at any supermarket, each promoted as a cure for various ills: digestive issues, fatigue, weak immunity, brain fog, and more. While the evidence on these benefits is lacking, the marketing messages are working; the global probiotic market was worth about $49.4 billion in 2018, and forecasting experts estimate it will grow to $69.3 billion by 2023. Prebiotics, the fibers that feed probiotics, have been riding the coattails of this popularity for some time. Now postbiotics—the microbes produced when probiotics eat prebiotics—have hit the scene. They’re being sold as supplements and are starting to make the rounds on nutrition-focused corners of the internet.

The hype around all of these microbes makes sense. Yes, prebiotics, probiotics, and postbiotics can enhance health by positively influencing the microbiome, a term that refers to the multitudes of microorganisms that live within you, explains Carolina Guizar, a New York–based dietitian and owner of the nutrition-coaching platform Eathority. But as with probiotics and prebiotics, the postbiotic market is several steps ahead of the actual science.

While the microbiome has been a hot topic among nutrition experts (and amateur enthusiasts) for about a decade, microbiome research is still in the very early stages. A 2018 review of the literature published in the European Journal of Nutrition starts its conclusion with: “The role of the human gut microbiota in health and disease is beginning to be understood.” The authors tell us what we know, which is that the gut microbiome plays a role in mood regulation, cognition, immune function, and digestive health. But they also explain that the details are still unclear: we aren’t exactly sure what the benefits are, how the various microbes deliver them, and whether or not supplements offer any measurable benefits. Here’s what experts have to say about the state of the evidence.

It’s All Connected

We can’t talk about postbiotics without first talking about prebiotics and probiotics, because none of them stand alone. Probiotics are beneficial bacteria that live naturally in your microbiome. Your microbiome exists all over your body, but here we’re talking primarily about your gut.

Probiotics are powerful. A 2019 review in Future Science OA found significant evidence for the digestive benefits of probiotics and promising evidence for their potential impact on mood and mental health. But it’s not as simple as just taking one supplement and expecting something to happen, explains George Weinstock, a University of Connecticut professor and the director of microbial genomics at the Jackson Laboratory, a global nonprofit biomedical research institute. “Probiotics” is an umbrella term for a variety of different bacteria. Roughly 5,000 strains from 1,000 species have been found in the human gut microbiome, although not everyone has all of them. Each strain acts slightly differently and has different potential health benefits.

Probiotics can’t do their thing without the help of prebiotics, a type of fermentable fiber found in plant foods that feed probiotics and keep them alive. Tamara Duker Freuman, a New York–based dietitian and author of The Bloated Belly Whisperer, explains that when probiotics feed on prebiotics, they produce postbiotics, health-promoting by-products called microbial short-chain fatty acids. As with probiotics, “postbiotics” is an umbrella term that encompasses several different microbes, all with different characteristics and potential health benefits.

Skip the Supplements

“Microbiome research really only hit the headlines a little over ten years ago,” Weinstock says. Since then the market has exploded with supplements meant to improve the microbiome, and the public is increasingly interested in how food might affect it as well.

We know that a diet high in plant-based foods is key for the body’s production of prebiotics. “The main sources of prebiotics in the typical American diet are whole-wheat bread, onions, and garlic—but so many other foods contain them,” Freuman says. Many fruits and vegetables contain prebiotics, including apples, pears, mushrooms, artichokes, cauliflower, and jicama. Beans, lentils, barley, and rye also have significant amounts of prebiotic fiber. We need to consume prebiotic fibers regularly to reap their benefits—our bodies don’t naturally house them and can’t produce them. Since they’re so prevalent in common foods, supplements aren’t really necessary.

Probiotics are also present in our foods, primarily in fermented ones like yogurt, kimchi, sauerkraut, and cheese, and in supplements. But what many people don’t realize is that, generally speaking, probiotics from your diet don’t have a huge impact on your gut microbiome. There are somewhere around 100 trillion bacteria in your gut. “When you take a probiotic supplement or eat a food that contains probiotics, you’re introducing them to a habitat [your gut] that’s already densely populated with microorganisms,” Weinstock explains. A supplement may boast “one billion live probiotics,” but that’s just 0.001 percent of the bacteria already in your gut. Those one billion probiotics have to fight hard to colonize your already-packed microbiome and might end up just passing through your stool.

Weinstock also notes that although labels make it seem like probiotic supplements contain a huge variety and number of beneficial bacteria, this isn’t the case. Practically all probiotic supplements contain bacteria from just two genera: Lactobacillus and Bifidobacterium. The Food and Drug Administration deems them safe because they’re found in common foods that we’ve been eating for centuries, like cheese. So you’re not really getting any additional benefit from these supplements, because they only contain probiotic strains that are already in your diet.

Countless other potentially beneficial strains and species are being examined. This 2020 review in the International Journal of Microbiology summarizes recent studies looking into various probiotics for potential benefits ranging from diabetes prevention to HIV treatment. Remember, up to 5,000 strains have already been found in the human gut microbiome—but their effect on the body is not yet understood, so they’re not yet approved for sale or consumption. Even when other strains start being approved, you’ll only benefit from supplementation if you’re taking a strain that isn’t already present in large quantities in your gut.

“I don’t typically recommend probiotic supplements,” Freuman says. “There is such limited evidence that they do much of anything to change the microbiome in a meaningful way or contribute to enhanced gut health for most people.”

The evidence for postbiotic supplements is even more limited. “We don’t have enough information on the safety or efficacy of postbiotic supplements at this time,” Guizar says.

Freuman explains that a prebiotic-rich diet likely supports the existing probiotics in your gut, helping them to thrive. “If you are truly interested in diversifying your gut microbiome and increasing the abundance of health-promoting species, the research strongly supports that high-fiber diets that contain very diverse types of plant-based foods are a much more effective approach,” she says.

DIY, Don’t Buy

The short of it is that there’s really no need to think about postbiotics at all. “There is very little research as to whether taking postbiotics in supplement form does anything to enhance human health,” Freuman says.

That’s not to say that postbiotics aren’t beneficial. We know that these postbiotic microbes are health promoting. But why buy them in supplement form when your body is making them constantly? Part of the benefit of postbiotics likely comes from the prebiotic-postbiotic interaction—the breaking down of ingested prebiotics by health-promoting probiotics, which in itself can help you digest fiber more comfortably. You won’t reap this benefit from a postbiotic supplement. Weinstock adds that many postbiotic microbes are volatile and difficult to preserve on the supplement shelf.

“A much surer way to secure the health benefits of these postbiotics is to simply eat a healthy, diverse, fiber-rich diet,” Freuman says.

Sit Tight

If you’re excited about microbiome research and the potential uses and benefits of prebiotics, probiotics, and postbiotics, great. So are the researchers and clinicians who study them. But spending lots of time and money on supplements right now is jumping the gun.

“There’s this huge amount of work that has to go into studying our tissues, metabolites, microbes, all of that, to try and correlate them with all different types of diseases,” Weinstock says. Much of what’s being studied, like the effect of the microbiome on neurodegenerative diseases like Parkinson’s and Alzheimer’s, will take years to figure out, because these conditions manifest very slowly over time and have to do with things happening inside the body at extremely low levels. Weinstock is hopeful and excited about all of this. “We already have all of these microbes inside of us. We just need to figure out how to access them, how to use them,” he says. But it will take time before we can come to any real, actionable conclusions.

Ultimately, the vague potential of various microbes might be what drives such fanatical interest in them. “People want to feel like they have influence over their health,” Guizar says. No matter that probiotic and postbiotic supplements haven’t been shown to offer any substantial benefit for healthy people, or that the best way to get prebiotics is to eat the same nutritious diet that’s been recommended for decades. There’s so much we don’t know about these microbes. And for many, it’s hard to resist the idea that maybe, just maybe, a certain pill or specific supplement might have benefits beyond what the science currently understands.

via Outside Magazine: Nutrition

#IFTTT #Outside Magazine: Nutrition

0 notes

udaycmi · 4 years ago

Link

Get Sample copy of report: https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-sample

Polaris Market research has segmented the Human Microbiome Therapeutics market report on the basis region

Human Microbiome Therapeutics Regional Outlook (Revenue – USD Million, 2016 – 2027)

North America

· U.S.

· Canada

Europe

· France

· Germany

· UK

· Italy

· Netherlands

· Spain

· Austria

Asia Pacific

· China

· India

· Japan

· Malaysia

· Australia

· South Korea

Central & South America

· Mexico

· Brazil

· Argentina

Middle East & Africa

· UAE

· Saudi Arabia

· Israel

· South Africa

Get Discount: https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

0 notes

athiranair23 · 4 years ago

Text

Hepatic Encephalopathy Market Analysis (2020-2027)

Hepatic encephalopathy (HE) is the complication of advanced liver disease. Hepatic encephalopathy is a major challenge to the healthcare system due to frequent hospital contacts and admissions. Hepatic encephalopathy can be further divided into type A, type B, and type C that results from acute liver failure, portosystemic encephalopathy (PSS), and liver cirrhosis, respectively.

Market Dynamics

Key players are indulged in conducting clinical trials for the development of new therapeutic products for the treatment for liver diseases, which is expected to drive the global hepatic encephalopathy market growth over the forecast period. For instance, in December 2019, Kaleido Biosciences, Inc., a clinical-stage healthcare company announced positive results from a proof-of-concept clinical study, in which they used KB174, a novel microbiome metabolic therapy (MMT) in combination with a 15N-labeled tracer, a biomarker of microbiome ammonia production, in patients with liver cirrhosis. The treatment reduced the 15N urinary output and was well tolerated among the patients.

Market players are engaged in launching new products, in order to expand their market share, which is expected to spur growth of the market over the forecast period. For instance, in April 2015, Lupin Pharma Canada Limited, a subsidiary of Lupin Limited, launched Zaxine, indicated for the treatment of hepatic encephalopathy, under a strategic licensing agreement with the Salix Pharmaceuticals Inc. The agreement granted Lupin Pharma Canada Limited exclusive rights for the promotion, distribution, and marketing of Zaxine in Canada.

Key features of the study:

· This report provides an in-depth analysis of global hepatic encephalopathy market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2020 – 2027), considering 2019 as the base year

· It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market

· This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players

· It profiles leading players in the global hepatic encephalopathy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans

· Key companies covered as a part of this study include ASKA Pharmaceutical Co., Ltd., Cosmo Pharmaceuticals N.V., Lupin Limited, Kaleido Biosciences, Kannalife Sciences, Inc., Bausch Health Companies Inc., Ferring Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Umecrine Cognition AB, Norgine B.V., Abbott Laboratories, and QR Science and Technology Development Co. Ltd.

· Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

· The global hepatic encephalopathy market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts

· Stakeholders would have ease in decision making through various strategy matrices used in analyzing the hepatic encephalopathy market.

Detailed Segmentation:

· Global Hepatic Encephalopathy Market, By Drug Class:

o Antibiotics

o Laxatives

o L-ornithine L-aspartate

o Others

· Global Hepatic Encephalopathy Market, By Route of Administration:

o Oral

o Intravenous

o Rectal

· Global Hepatic Encephalopathy Market, By Distribution Channel:

o Hospital Pharmacies

o Retail Pharmacies

o Online Pharmacies

· Global Hepatic Encephalopathy Market, By Region:

o North America

§ By Country

§ U.S.

§ Canada

§ By Drug Class:

§ Antibiotics

§ Laxatives

§ L-ornithine L-aspartate

§ Others

§ By Route of Administration

§ Oral

§ Intravenous

§ Rectal

§ By Distribution Channel

§ Hospital Pharmacies

§ Retail Pharmacies

§ Online Pharmacies

o Latin America

§ By Country:

§ Brazil

§ Mexico

§ Argentina

§ Rest of Latin America

§ By Drug Class:

§ Antibiotics

§ Laxatives

§ L-ornithine L-aspartate

§ Others

§ By Route of Administration

§ Oral

§ Intravenous

§ Rectal

§ By Distribution Channel

§ Hospital Pharmacies

§ Retail Pharmacies

§ Online Pharmacies

o Europe

§ By Country:

§ U.K.

§ Germany

§ Italy

§ Spain

§ France

§ Russia

§ Rest of Europe

§ By Drug Class:

§ Antibiotics

§ Laxatives

§ L-ornithine L-aspartate

§ Others

§ By Route of Administration

§ Oral

§ Intravenous

§ Rectal

§ By Distribution Channel

§ Hospital Pharmacies

§ Retail Pharmacies

§ Online Pharmacies

o Asia Pacific

§ By Country:

§ Australia

§ India

§ China

§ Japan

§ ASEAN

§ South Korea

§ Rest of Asia Pacific

§ By Drug Class:

§ Antibiotics

§ Laxatives

§ L-ornithine L-aspartate

§ Others

§ By Route of Administration

§ Oral

§ Intravenous

§ Rectal

§ By Distribution Channel

§ Hospital Pharmacies

§ Retail Pharmacies

§ Online Pharmacies

o Middle East

§ By Country:

§ GCC

§ Israel

§ Rest of Middle East

§ By Drug Class:

§ Antibiotics

§ Laxatives

§ L-ornithine L-aspartate

§ Others

§ By Route of Administration

§ Oral

§ Intravenous

§ Rectal

§ By Distribution Channel

§ Hospital Pharmacies

§ Retail Pharmacies

§ Online Pharmacies

o Africa

§ By Country/Region:

§ South Africa

§ Central Africa

§ North Africa

§ By Drug Class:

§ Antibiotics

§ Laxatives

§ L-ornithine L-aspartate

§ Others

§ By Route of Administration

§ Oral

§ Intravenous

§ Rectal

§ By Distribution Channel

§ Hospital Pharmacies

§ Retail Pharmacies

§ Online Pharmacies

· Company Profiles

o ASKA Pharmaceutical Co.*

§ Company Overview

§ Product Portfolio

§ Financial Performance

§ Recent Highlights

§ Strategies

o Cosmo Pharmaceuticals N.V.

o Lupin Limited

o Kaleido Biosciences

o Kannalife Sciences, Inc.

o Bausch Health Companies Inc.

o Ferring Pharmaceuticals Inc.

o Mallinckrodt Pharmaceuticals

o Umecrine Cognition AB

o Norgine B.V.

o Abbott Laboratories

o QR Science and Technology Development Co. Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Request sample copy here :

https://www.coherentmarketinsights.com/insight/request-sample/2596

Request PDF brochure here:

https://www.coherentmarketinsights.com/insight/request-pdf/2596

Click here to buy: https://www.coherentmarketinsights.com/insight/buy-now/2596

CMI Services: https://www.coherentmarketinsights.com/services

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

· Customized Market Research Services

· Industry Analysis Services

· Business Consulting Services

· Market Intelligence Services

· Long term Engagement Model

· Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email : [email protected]

Reference/Source: https://www.coherentmarketinsights.com/market-insight/hepatic-encephalopathy-market-2596

#CoherentMarketInsights #MarketAnalysis #Healthcare #Marketresearch

0 notes

businessconsultingarticle · 3 years ago

Text

Probiotic Cosmetic Products Market Size, Key Market Players, SWOT, Revenue Growth Analysis, 2020–2028

The global probiotic cosmetic products market size was valued at USD 268.91 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.5% during the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3837

Segments Covered in the Report For the purpose of this study, Reports and Data has segmented the global probiotic cosmetic products market report on the basis of product, distribution channel, and region: